Jacqueline A. French, MD: Cenobamate's Future Impact in Seizure Control
The professor of neurology at NYU Langone discussed cenobamate’s potential as a treatment option for patients who have uncontrolled seizures, as well as its ability to bring a high number of patients toward complete seizure freedom.
“The data support a significant number of patients not only having a reduction in seizures but having complete seizure freedom over some prolonged period of time. As epileptologists, that’s quite exciting to us because the number of patients who actually become seizure-free is relatively small in any of the cohorts that go into clinical trials.”
Jacqueline A. French, MD, professor of neurology, NYU Langone Medical Center, and colleagues presented a number of data on cenobamate at the
After the
To find out more about what the data reveal, NeurologyLive sat with French at AES 2019 to discuss cenobamate’s potential as a treatment option for patients who have uncontrolled seizures, as well as its ability to bring a high number of toward complete seizure freedom.
For more coverage of AES 2019,
REFERENCES
1. French JA, Chung SS, Krauss GL, et al. Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: open-label extension of a randomized clinical study. Presented at: 2019 American Epilepsy Society Annual Meeting. December 6-10, 2019; Baltimore, Maryland. Abstract 3.297.
2. Klein P, Krauss GL, Aboumatar S, Kamin M. Long-term efficacy and safety of adjunctive cenobamate in patients with uncontrolled focal seizures: open-label extension of a randomized clinical study. Presented at: 2019 American Epilepsy Society Annual Meeting. December 6-10, 2019; Baltimore, Maryland. Abstract 2.206.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Current Challenges and New Opportunities Ahead for Women in Neurology
September 15th 2025
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025